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Purpose of the study
Raltegravir (RAL) is an HIV-1 integrase strand-transfer
inhibitor that has exhibited substantial efficacy and a
favorable safety profile in HIV-1 infected patients. The
goal of this study was to explore the presence of natural
polymorphisms and primary mutations related to RAL
resistance among HIV-1 patients failing to multiple anti-
retroviral agents.
Methods
25 plasmas from HIV-1 infected patients with HAART
failure were studied. Genetic analysis was performed
amplifying and sequencing DNA encompassing 288
amino acids of HIV-1 integrase gene. Drug resistance
mutations and polymorphisms were examined following
Low et al, 2009. Genetic subtypes were analyzed using
REGA HIV Subtyping Tool (http://www.bioafrica.net/
subtypetool/html/subtypinghiv.html).
Results
Of the 25 patients, 15 were males and 10 females. All of
them are more than 18 years old and 19 patients born
in Sao Paulo city. 22 patients were infected by HIV-1
subtype B, 1 by subtype F and 2 by B/F recombinants.
No Raltegravir resistance related mutations were
observed, however we identified following polymorph-
isms: V72I (44%), T97A (4%), Q146K (4%), V151I (28%),
V201I (52%), T206S (8%), I203M (12%), S230N (4%),
M154L (4%), K156N (16%) e K156R (4%). Furthermore,
we observed amino acid substitutions at codons 163 in
two patients (G163E and G163V) and 138 in one patient
(E138N).
Conclusions
Despite the absence of RAL primary resistance muta-
tions, we found a high frequency of polymorphisms that
were related to in vitro reduced susceptibility to RAL.
Furthermore, substitutions at codons 163 (G163R) and
138 (E138K) are called secondary mutations, which are
capable to restore viral fitness due to the presence of
primary mutations. Further studies are needed to deter-
mine the importance of these polymorphisms in redu-
cing the genetic barrier to RAL resistance among
treated individuals.
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